Growth suppression activity of bradykinin antagonists in glioma cells
The present study was Aimed at analyzing the effect of bradykinin (BK) antagonists on proliferation of the human glioblastoma cells U373. Methods. MTT-based cell proliferation assay. Results. BKM-570 revealed a significant antiproliferative activity in the U373 cells with LC50 3,8 M. Conclusions. Th...
Збережено в:
Дата: | 2014 |
---|---|
Автори: | , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут молекулярної біології і генетики НАН України
2014
|
Назва видання: | Вiopolymers and Cell |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/153733 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Growth suppression activity of bradykinin antagonists in glioma cells / S.S. Avdieiev, L. Gera, R. Hodges, Y.S. Vassetzky, V.M. Kavsan // Вiopolymers and Cell. — 2014. — Т. 30, № 1. — С. 77-79. — Бібліогр.: 7 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of UkraineРезюме: | The present study was Aimed at analyzing the effect of bradykinin (BK) antagonists on proliferation of the human glioblastoma cells U373. Methods. MTT-based cell proliferation assay. Results. BKM-570 revealed a significant antiproliferative activity in the U373 cells with LC50 3,8 M. Conclusions. The antiproliferative properties of BK antagonists were shown in vitro using the glioma cells. Further investigations of the molecular mechanisms of their action and pre-clinical studies on animal models are needed for the evaluation of these compounds as new anti-cancer drugs. |
---|